Brought to you by 
Kaleido Biosciences goes public netting $69.8mm
04 Mar 2019
Executive Summary
Kaleido Biosciences Inc. netted $69.8mm in its initial public offering of 5mm common shares at $15 each on the Nasdaq. The company had planned to sell 4.76mm shares between $20 and $22.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com